Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?

Overview of attention for article published in Frontiers in Bioengineering and Biotechnology, September 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 3 X users

reddit: 2 Redditors

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 53 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 13 publications that cite this research output.

13

The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.

Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS)

Article in International Journal of Pharmaceutics (April 2024)

Low-dose intrapulmonary drug delivery device for studies on next-generation therapeutics in mice

Article in Journal of Controlled Release (June 2023)

Polypharmacology of ambroxol in the treatment of COVID-19

Article in Bioscience Reports (February 2023)